# Quail Egg Immunoglobulins (Coturnix coturnix)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/quail-egg-immunoglobulins
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 2 / 10
**Category:** Protein
**Also Known As:** Coturnix coturnix japonica immunoglobulins, Japanese quail egg antibodies, Quail IgY, Avian immunoglobulin Y from quail, Coturnix immunoglobulins, Quail egg yolk antibodies, QEI

## Overview

Quail egg immunoglobulins are antibody proteins extracted from Coturnix coturnix eggs that contain IgY-class immunoglobulins targeting pathogens such as Salmonella and Helicobacter pylori. Their primary mechanism involves modulating Th2-skewed immune responses by reducing pro-allergic [cytokine](/ingredients/condition/inflammation)s including IL-4, IL-5, and IL-13, as demonstrated in preliminary animal studies.

## Health Benefits

• May reduce allergic inflammation by decreasing IgE and IgG1 levels (preliminary mouse model evidence)
• Potentially modulates immune response through reduction of Th2/ILC2 cytokines (animal study only)
• Contains pathogen-specific antibodies against Salmonella and H. pylori (in-vitro binding studies only)
• May increase [anti-inflammatory](/ingredients/condition/inflammation) IL-10 levels in inflamed tissues (mouse model data)
• Could inhibit NF-κB p65 transcription factor activity in allergic responses (preliminary animal evidence)

## Mechanism of Action

Quail egg immunoglobulins, primarily IgY-class antibodies, exert immune-modulating effects by binding allergen epitopes and pathogen surface antigens, thereby blocking receptor-mediated activation of mast cells and basophils. In murine allergy models, oral or injected preparations suppressed Th2 and ILC2 [cytokine](/ingredients/condition/inflammation) cascades—specifically reducing IL-4, IL-5, IL-13, and TSLP signaling—which consequently lowered circulating IgE and IgG1 antibody titers. Pathogen-specific IgY fractions bind outer membrane proteins of Salmonella spp. and CagA/VacA antigens of H. pylori in vitro, potentially preventing epithelial adhesion and colonization.

## Clinical Summary

The current evidence base for quail egg immunoglobulins is largely preclinical. Mouse model studies of allergic [inflammation](/ingredients/condition/inflammation) demonstrated measurable reductions in serum IgE and IgG1 levels following immunoglobulin administration, with concomitant suppression of Th2/ILC2-associated cytokines; however, sample sizes in these studies were small (typically n=6–10 per group). In vitro binding assays confirm that quail egg-derived IgY antibodies exhibit affinity for Salmonella and H. pylori antigens, but no peer-reviewed randomized controlled trials in humans have been published to date. The evidence is therefore insufficient to make definitive clinical recommendations, and human pharmacokinetic and efficacy data remain absent.

## Nutritional Profile

Quail egg immunoglobulins are a concentrated protein fraction derived from Coturnix coturnix eggs, primarily sourced from egg yolk (IgY antibodies) and egg white. Protein content is high, typically 85-95% on a dry weight basis when in purified/concentrated supplement form. The dominant immunoglobulin class is IgY (the avian equivalent of mammalian IgG), with reported concentrations of approximately 15-25 mg IgY per mL of raw egg yolk, translating to roughly 1.5-3.5 mg IgY per gram of whole quail egg. Egg white fractions contribute IgA-like and IgM-like antibody species at lower concentrations (estimated <1 mg/g whole egg). Bioactive compounds include glycoproteins with N-linked oligosaccharide chains (galactose, mannose, N-acetylglucosamine residues), which may influence mucosal binding activity. Lipid content is minimal in purified immunoglobulin fractions (<2% on dry weight basis), though crude extracts retain yolk lipids including phosphatidylcholine and cholesterol. Micronutrient co-occurrence in crude preparations includes riboflavin (~0.3 mg/100g), selenium (~25 µg/100g), and vitamin B12 (~1.4 µg/100g), though these are substantially reduced in purified immunoglobulin isolates. Bioavailability: IgY antibodies are largely resistant to gastric acid degradation at physiological pH ranges of 4-7 but show significant denaturation below pH 3.5, suggesting partial survival through gastrointestinal transit when buffered; enteric coating or microencapsulation in supplement forms is used to improve functional delivery. Oral bioavailability of intact immunoglobulins into systemic circulation is considered negligible; primary activity is thought to be luminal/mucosal rather than systemic absorption.

## Dosage & Preparation

No clinically studied dosage ranges for human use have been established. Animal studies used daily oral quail egg homogenate (dose unspecified) administered for 21 days in mice. No standardized extract dosing data is available for humans. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Quail egg immunoglobulins carry a meaningful allergy risk for individuals with egg hypersensitivity, as IgY preparations retain egg protein residues that can trigger IgE-mediated reactions including anaphylaxis. No formal drug interaction studies exist, but theoretical concern applies to immunosuppressive medications (e.g., corticosteroids, calcineurin inhibitors) where additive [immune modulation](/ingredients/condition/immune-support) is unpredictable. Pregnant and breastfeeding individuals should avoid supplementation due to a complete absence of safety data in these populations. No established standardized dosage has been validated in human trials, making safe dose guidance impossible at this time.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses on quail egg immunoglobulins were identified. Available evidence is limited to preclinical animal models, including a mouse study of peanut-induced eosinophilic esophagitis (PMC5773610) and antibody production studies in immunized quails showing high-titer anti-Salmonella and anti-H. pylori IgY production.

## Historical & Cultural Context

No evidence of historical or traditional medicinal use of quail egg immunoglobulins was found in any traditional systems. Research focuses exclusively on modern antibody production for potential immunotherapy applications.

## Synergistic Combinations

[Probiotic](/ingredients/condition/gut-health)s, Quercetin, Vitamin D3, Zinc, Bovine colostrum

## Frequently Asked Questions

### What are quail egg immunoglobulins and how are they different from chicken egg antibodies?

Quail egg immunoglobulins are IgY-class antibodies found in Coturnix coturnix egg yolks, structurally analogous to mammalian IgG but encoded by avian immune genetics. Compared to chicken-derived IgY, quail IgY may carry distinct pathogen-specific epitope profiles—particularly against Salmonella and H. pylori—though direct comparative efficacy data in humans are not yet available.

### Can quail egg immunoglobulins help with seasonal allergies?

Preliminary mouse model research suggests quail egg immunoglobulins can reduce serum IgE levels and suppress Th2 cytokines like IL-4 and IL-5, which drive allergic inflammation in conditions like hay fever. However, no human clinical trials have tested this effect in seasonal allergic rhinitis, so using them for allergy management remains speculative and unsupported by human evidence.

### Do quail egg immunoglobulins survive digestion to work in the gut?

IgY antibodies from avian eggs have moderate acid stability compared to mammalian IgG, but significant proteolytic degradation by pepsin and pancreatic enzymes occurs in the gastrointestinal tract, reducing bioavailability. Microencapsulation or enteric coating technologies are under investigation to improve IgY survival through the stomach, but no validated delivery system for quail egg immunoglobulins has been confirmed in human studies.

### Is it safe to take quail egg immunoglobulin supplements if I have an egg allergy?

No—individuals with diagnosed egg allergy should avoid quail egg immunoglobulin supplements, as the IgY preparations are derived from egg yolk and may retain allergenic proteins such as ovomucoid and ovalbumin that trigger IgE-mediated hypersensitivity reactions. Even partial purification does not guarantee complete allergen removal, and reactions ranging from urticaria to anaphylaxis are plausible risks.

### What is the effective dosage of quail egg immunoglobulins for immune support?

No validated human clinical dosage has been established for quail egg immunoglobulins, as published research is limited to in vitro binding studies and small-sample murine models without dose-escalation trials. Animal studies have used variable IgY concentrations without a consistent effective dose being identified, meaning any dosage listed on commercial supplements lacks human efficacy validation at this time.

### What does current clinical research show about quail egg immunoglobulins for human health?

Most evidence for quail egg immunoglobulins comes from animal models and in-vitro studies rather than human clinical trials. Available research suggests potential benefits for immune modulation and allergic inflammation reduction, but these findings have not been replicated in large-scale human studies. More rigorous clinical research is needed before making strong claims about efficacy in people.

### Are quail egg immunoglobulin supplements safe for children?

Limited safety data exists specifically for quail egg immunoglobulin supplements in children, as most studies have been conducted in animal models. While quail eggs themselves are generally considered safe for children over 12 months old, concentrated immunoglobulin supplements should only be given under pediatric guidance. Parents should consult with a healthcare provider before giving this supplement to children.

### How do quail egg immunoglobulins compare to probiotics for gut immune health?

Quail egg immunoglobulins and probiotics work through different mechanisms—immunoglobulins provide passive antibodies while probiotics establish beneficial bacterial strains. There is currently no direct comparative research in humans showing which approach is more effective for gut immunity. Some individuals may benefit from combining both approaches, but this strategy requires personalized medical assessment.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*